✦ LIBER ✦

A 5-year randomized study to investigate the safety of pimecrolimus cream 1% in the treatment of mild-to-moderate atopic dermatitis in infants: Immunologic parameters

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 5-year randomized study to investigate

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Review of pimecrolimus cream 1% for the

✍ Adelaide A. Hebert 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 836 KB

Skin physiological parameters confirm th

✍ Roland Aschoff; Uta Schwanebeck; Matthias Bräutigam; Michael Meurer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Safety and efficacy of pimecrolimus (ASM

✍ Lawrence F. Eichenfield; Anne W. Lucky; Mark Boguniewiczc; Richard G.B. Langley; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 238 KB

The effect of pimecrolimus cream 1% twic

✍ Joseph F Fowler Jr.; Anthony Johnson; Ken Abrams 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

A randomized investigator-blinded study

✍ Steven Kempers; Mark Boguniewicz; Eric Carter; Michael Jarratt; David Pariser; D 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 218 KB